EUVIMEDEUVIMED entdecken
Crossref

Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia

Liyan Yang, Huiqin Zhang, Yansong Wei, Haiyue Niu, Yumei Liu, Tian Zhang, Limin Xing, Zonghong Shao, Rong Fu iD, Huaquan Wang iD

American Journal of Hematology · 2026-07 · 101 (7) · 1443-1450

DOI: 10.1002/ajh.70311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 01.04.2026. Verfasst von Liyan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Red-Cell Aplasia, Pure, Mutation, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Program of Tianjin Natural Science Fundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppressive therapy (IST) is the standard treatment for acquired pure red cell aplasia (aPRCA), but predictors of treatment response and long‐term prognosis remain unclear. The clinical significance of somatic mutations in aPRCA is not fully understood. We retrospectively analyzed 69 adult aPRCA patients who underwent targeted next‐generation sequencing of 69 genes associated with clonal hematopoiesis and myeloid neoplasms. Somatic mutations, T‐cell receptor (TCR) gene rearrangements, treatment response at 6 months, overall survival (OS), and progression‐free survival (PFS) were evaluated. Somatic mutations were detected in 62.3% of patients, mainly in epigenetic regulators like DNMT3A and TET2 . Although mutations did not predict 6‐month response to IST, higher mutation burden was associated with worse treatment outcomes ( p = 0.01). TP53 and DNMT3A mutations were linked to shorter OS and PFS. Survival worsened with increasing mutation numbers, while mutations in TET2 , ASXL1 , GATA2 , and STAT3 had no significant effect. TCR gene rearrangements were common in large granular lymphocyte leukemia‐associated aPRCA but did not affect treatment response or survival. Somatic mutations are common in aPRCA and reflect clonal hematopoiesis. Mutation burden is a key determinant of IST response, while TP53 and DNMT3A mutations signal poorer long‐term outcomes. Mutational profiling may improve risk stratification and guide personalized management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Red-Cell Aplasia, PureMutationImmunosuppressive AgentsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAdultClonal HematopoiesisTreatment OutcomeDNA Methyltransferase 3ADioxygenasesAged, 80 and overHigh-Throughput Nucleotide SequencingDNA-Binding ProteinsPrognosis

Substanzen

DNA Methyltransferase 3AImmunosuppressive AgentsDioxygenasesDNMT3A protein, humanDNA-Binding ProteinsTET2 protein, human

Autor:innen und Institutionen

  • Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Department of Hematology, the Second Affiliated Hospital, Tianjin Medical University, Tianjin, China.
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Rong Fu, Huaquan Wang

Förderung

  • National Natural Science Foundation of China
  • Key Program of Tianjin Natural Science Fundation

Zitieren

APA

Yang, L., Zhang, H., Wei, Y., Niu, H., Liu, Y., Zhang, T., Xing, L., Shao, Z., Fu, R., & Wang, H. (2026). Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia. American Journal of Hematology, 101(7), 1443-1450. https://doi.org/10.1002/ajh.70311

Vancouver

Yang L, Zhang H, Wei Y, Niu H, Liu Y, Zhang T, et al. Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia. American Journal of Hematology. 2026;101(7):1443-1450. doi:10.1002/ajh.70311

BibTeX
@article{Yang2026,
  author = {Yang, Liyan and Zhang, Huiqin and Wei, Yansong and Niu, Haiyue and Liu, Yumei and Zhang, Tian and Xing, Limin and Shao, Zonghong and Fu, Rong and Wang, Huaquan},
  title = {Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {7},
  pages = {1443--1450},
  doi = {10.1002/ajh.70311}
}
Kostenlos starten →